DMAA
Drugs Made In America Acquisition Corp.Company with tickers: DMAA, DMAAR, DMAAU
Market Cap
$258.31M
Shares Outstanding
24,276,913
CIK
2028614
CUSIP
G2847J104
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-05 | 2026-04-29 | |
| 8-K | 2026-05-01 | 2026-04-27 | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| 10-K | 2026-04-15 | 2025-12-31 | |
| DEF 14A | 2026-04-14 | 2026-04-27 | |
| 8-K | 2026-04-08 | 2026-04-07 | |
| 8-K | 2026-03-27 | 2026-03-23 | |
| 8-K | 2026-03-06 | — | |
| 8-K | 2026-03-06 | 2026-02-28 | |
| 8-K | 2025-11-18 | 2025-10-08 | |
| 10-Q | 2025-11-18 | 2025-09-30 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 10-Q | 2025-05-20 | 2025-03-31 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-02-25 | 2025-02-18 | |
| 8-K | 2025-02-24 | 2025-02-20 | |
| 8-K | 2025-02-04 | 2025-01-29 | |
| 8-K | 2025-01-30 | 2025-01-27 |
Showing 1–19 of 19 filings